-
1
-
-
0036197952
-
-
Greist JH, Mundt JC, Kobak KA. Factors contributing to failed trials of new agents: can technology prevent some problems? J Clin Psychiatry. 2002: 63 (suppl 2): 8-13.
-
Greist JH, Mundt JC, Kobak KA. Factors contributing to failed trials of new agents: can technology prevent some problems? J Clin Psychiatry. 2002: 63 (suppl 2): 8-13.
-
-
-
-
2
-
-
33846245890
-
-
Kobak KA, Kane JM, Thase ME, et al. Why do clinical trials fail?: the problem of measurement error in clinical trials: time to test new paradigms? J Clin Psychopharmacol. 2007: 27 (1): 1-5.
-
Kobak KA, Kane JM, Thase ME, et al. Why do clinical trials fail?: the problem of measurement error in clinical trials: time to test new paradigms? J Clin Psychopharmacol. 2007: 27 (1): 1-5.
-
-
-
-
3
-
-
77952185894
-
-
Kobak KA, Leuchter A, DeBrota D, et al. Site versus centralized raters in a clinical depression trial: impact on patient selection and placebo response. J Clin Psychopharmacol. 2010; 30 (2): 193-197.
-
Kobak KA, Leuchter A, DeBrota D, et al. Site versus centralized raters in a clinical depression trial: impact on patient selection and placebo response. J Clin Psychopharmacol. 2010; 30 (2): 193-197.
-
-
-
-
4
-
-
0030732606
-
Comparability of telephone and face-to-face interviews in assessing Axis I and II disorders.
-
Rohde P, Lewinsohn PM, Seeley JR. Comparability of telephone and face-to-face interviews in assessing Axis I and II disorders. Am J Psychiatr. 1997; 154: 1593-1598.
-
Rohde P, Lewinsohn PM, Seeley JR. Comparability of telephone and face-to-face interviews in assessing Axis I and II disorders. Am J Psychiatr. 1997; 154: 1593-1598.
-
(1997)
Am J Psychiatr
, vol.154
, pp. 1593-1598
-
-
Rohde, P.1
Lewinsohn, P.M.2
Seeley, J.R.3
-
5
-
-
40849098650
-
Re-defining affective disorders: relevance for drug development.
-
Targum SD, Pollack MH, Fava M. Re-defining affective disorders: relevance for drug development. CNS Neurosci Ther. 2008; 14: 2-9.
-
Targum SD, Pollack MH, Fava M. Re-defining affective disorders: relevance for drug development. CNS Neurosci Ther. 2008; 14: 2-9.
-
(2008)
CNS Neurosci Ther
, vol.14
, pp. 2-9
-
-
Targum, S.D.1
Pollack, M.H.2
Fava, M.3
-
6
-
-
85026183978
-
-
Schoemaker J, Gaur R, Chawla V, et al. Expert Rater Assisted Score Evaluation (ERASE): a new method to enhance signal detection in randomized, placebo-controlled clinical trials. Presented at the 49th Annual NCDEU, Hollywood, FL; June 29 to July 2, 2009.
-
Schoemaker J, Gaur R, Chawla V, et al. Expert Rater Assisted Score Evaluation (ERASE): a new method to enhance signal detection in randomized, placebo-controlled clinical trials. Presented at the 49th Annual NCDEU, Hollywood, FL; June 29 to July 2, 2009.
-
-
-
-
7
-
-
85026162936
-
-
Chandler G, Targum SD, Pollack M, et al. Validation of patients for a CNS trial of major depressive disorder. Presented at the 49th Annual NCDEU meeting, Hollywood, FL; July 1, 2009.
-
Chandler G, Targum SD, Pollack M, et al. Validation of patients for a CNS trial of major depressive disorder. Presented at the 49th Annual NCDEU meeting, Hollywood, FL; July 1, 2009.
-
-
-
-
8
-
-
85026175420
-
-
Dunn J. Comparison of site-based versus centralized ratings in a study of generalized anxiety disorder. Presented at the 163rd Annual APA meeting, New Orleans, LA; May, 2010.
-
Dunn J. Comparison of site-based versus centralized ratings in a study of generalized anxiety disorder. Presented at the 163rd Annual APA meeting, New Orleans, LA; May, 2010.
-
-
-
-
9
-
-
0034656321
-
Penny wise and dollar foolish: the impact of measurement error on sample size requirements in clinical trials.
-
Perkins DO, Wyatt RJ, Bartko JJ. Penny wise and dollar foolish: the impact of measurement error on sample size requirements in clinical trials. Biol Psychiatr. 2000; 47: 762-766.
-
(2000)
Biol Psychiatr
, vol.47
, pp. 762-766
-
-
Perkins, D.O.1
Wyatt, R.J.2
Bartko, J.J.3
|